Implications of Study Designs in BioMedicine and Clinical Trials: A Case Study of Currently Marketed anti-IL5 Biologics

Implications of Study Designs in BioMedicine and Clinical Trials: A Case Study of Currently Marketed anti-IL5 Biologics

Thursday, April 1, 2021 4:00 PM to 4:20 PM · 20 min. (Africa/Abidjan)
Antibodies
Showcase
Presentation

Information

· A discussion on study design considerations that go beyond study success as defined by a statistically significant primary outcome. 

· A short case study of three anti-eosinophilic currently marketed biologics (Mepolizumab, Reslizumab, and Benralizumab) for treating severe asthma. 

· A short presentation on the expertise and capability inherent in the Clinical Trials Practice at Westat to partner and assist early biotech, established biopharma, and other institutions working to

discover, develop, and market small molecule drugs, biologics, and diagnostics

Deepak Khatry, Head of Clinical Trials Biostatistics, Westat 

WestatWestat is a leader in designing, managing, monitoring, and delivering advanced clinical trials and epidemiologic studies. Building on more than 50 years of respected research, we serve as a CRO for forward-thinking biopharma companies investigating promising new drugs and therapeutics to address some of the world’s most pressing health challenges. We work side by side with our clients becoming an extension of their team, designing and implementing innovative, rigorous, credible clinical trials that deliver high value and cost efficiency. Our services are comprehensive –from protocol concept, site selection, patient recruitment, and study execution to post-trial reporting, data analysis, and regulatory approvals to help clients smoothly navigate all facets of the clinical trials process. We support clinical research in chronic and infectious diseases, and support research in vaccine, gene therapy, monoclonal antibody, and chemotherapy interventions. Our expert interdisciplinary team includes epidemiologists, biostatisticians, data managers, and regulatory affairs associates. Biopharma companies can count on Westat Commercial Life Sciences to partner with them every step of the way –addressing challenges with creativity, integrity, and a honed, expert focus on results.

Log in